Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 476 publications
Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group.
Journal: Nature reviews. Urology
Published: July 22, 2026
International Society of Urological Pathology Multidisciplinary Expert Consultation Conference on Evaluation of Treatment Effects in Prostate and Bladder Cancer: Working Group 2: The Urinary Bladder.
Journal: The American journal of surgical pathology
Published: May 22, 2026
Development and validation of a computational histology artificial intelligence-powered prognostic biomarker in muscle-invasive bladder cancer.
Journal: Urologic oncology
Published: May 18, 2026
'BJUI Clinical Dilemma': Recurrent high-grade non-muscle-invasive bladder cancer in 2026.
Journal: BJU international
Published: April 28, 2026
Systemic induction therapy and the expanding frontier of bladder preservation in MIBC.
Journal: Nature reviews. Clinical oncology
Published: April 22, 2026
Evaluating the Surrogacy of Pathological Complete Response at Radical Cystectomy in Neoadjuvant-based Muscle-invasive Bladder Cancer Trials.
Journal: European urology oncology
Published: April 21, 2026
Reducing complexity in International Bladder Cancer Group intermediate-risk non-muscle-invasive bladder cancer stratification: a three-factor approach.
Journal: BJU international
Published: April 02, 2026
Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensus.
Journal: Nature reviews. Urology
Published: March 11, 2026
Bacillus Calmette-Guérin (BCG) and Beyond: Is Systemic Immunotherapy for BCG-Naïve Non-Muscle-Invasive Bladder Cancer Progress or Overreach?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 02, 2026
Histological Subtypes and Divergent Differentiation of Urothelial Carcinoma: Histology, Genomics, and Management Implications.
Journal: European urology
Published: February 20, 2026
Re: Kitamura H, Tsukamoto T, Kakehi Y, et al. Active surveillance versus intravesical bacillus Calmette-Guérin for high-grade T1 bladder cancer with negative second transurethral resection: the randomized noninferiority phase 3 JCOG1019 trial. Eur Urol. 2026;89:437-445.
Journal: European urology
Published: February 16, 2026
Last Updated: 09/26/2026